ヘルプ
ヘルプ

検索結果 8,325 件

Hepatology

Hepatology
紙雑誌
Wiley Company<Z54-D691>
国立国会図書館全国の図書館
  •  
  •  
  •  
  •  
  •  
    •  

Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
デジタル記事
2023-11-20Hepatology79 3p.E93-E94
全国の図書館
  • 掲載誌（ISSN）02709139

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
デジタル記事
2023-05-22Hepatology78 6p.1922-1965
全国の図書館
  • 掲載誌（ISSN）02709139

Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event

Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event
デジタル記事
2023-05-17Hepatology78 4p.1149-1158
全国の図書館
  • 掲載誌（ISSN）02709139

Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis

Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis
デジタル記事
2023-05-03Hepatology78 5p.1506-1524
全国の図書館
  • 掲載誌（ISSN）02709139

Intermittent fasting—the future treatment in NASH patients?

Intermittent fasting—the future treatment in NASH patients?
デジタル記事
2023-04-17Hepatology78 4p.1290-1305
全国の図書館
  • 掲載誌（ISSN）02709139

Direct chemical induction of hepatocyte‐like cells with capacity for liver repopulation

Direct chemical induction of hepatocyte‐like cells with capacity for liver repopulation
デジタル記事
2023-04-17Hepatology77 5p.1550-1565
全国の図書館
  • 掲載誌（ISSN）02709139

P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis

P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
デジタル記事
2023-04-17Hepatology77 5p.1499-1511
全国の図書館
  • 掲載誌（ISSN）02709139

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
デジタル記事
2023-04-06Hepatology78 2p.397-415
全国の図書館
  • 掲載誌（ISSN）02709139

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
デジタル記事
2023-03-17Hepatology77 5p.1797-1835
全国の図書館
  • 掲載誌（ISSN）02709139

Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality

Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
デジタル記事
2023-02-17Hepatology77 3p.942-948
全国の図書館
  • 掲載誌（ISSN）02709139

TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia

TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia
デジタル記事
2023-01-03Hepatology77 5p.1639-1653
全国の図書館
  • 掲載誌（ISSN）02709139

Overcoming T-cell exhaustion: New therapeutic targets in HCC immunotherapy

Overcoming T-cell exhaustion: New therapeutic targets in HCC immunotherapy
デジタル記事
2023-01-03Hepatology78 4p.1009-1011
全国の図書館
  • 掲載誌（ISSN）02709139

A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases

A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases
デジタル記事
2022-12-07Hepatology77 4p.1428-1455
全国の図書館
  • 掲載誌（ISSN）02709139

A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases

A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases
デジタル記事
2022-12-07HepatologyPublish Ahead of Print
全国の図書館
  • 掲載誌（ISSN）02709139

Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study

Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study
デジタル記事
2022-10-17Hepatology77 2p.489-500
全国の図書館
  • 掲載誌（ISSN）02709139

Acute hepatitis of unknown origin in children: Behind the statistics

Acute hepatitis of unknown origin in children: Behind the statistics
デジタル記事
2022-08-09Hepatology77 6p.2118-2127
全国の図書館
  • 掲載誌（ISSN）02709139

NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity

NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
デジタル記事
2022-07-30Hepatology78 2p.468-485
全国の図書館
  • 掲載誌（ISSN）02709139

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease
デジタル記事
2022-07-15Hepatology77 4p.1303-1318
インターネットで読める全国の図書館
  • 掲載誌（ISSN）02709139

Eosinophils protect against acetaminophen‐induced liver injury through cyclooxygenase‐mediated IL‐4/IL‐13 production

Eosinophils protect against acetaminophen‐induced liver injury through cyclooxygenase‐mediated IL‐4/IL‐13 production
デジタル記事
2022-07-15Hepatology77 2p.456-465
全国の図書館
  • 掲載誌（ISSN）02709139